Viracta Therapeutics, Inc.
EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY
Last updated:
Abstract:
Described herein are methods and compositions useful for augmenting cell-based immunotherapies. The augmented cell-based immunotherapies can be used to treat individuals with cancer and chronic viral infections.
Status:
Application
Type:
Utility
Filling date:
11 Jan 2019
Issue date:
26 Nov 2020